Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment?

B. Lepper, F. Ahrens, J. Weigl, F. Riedel (Hamburg, Kiel, Germany)

Source: Annual Congress 2006 - Pneumonia and other invasive pulmonary infections in children
Session: Pneumonia and other invasive pulmonary infections in children
Session type: Poster Discussion
Number: 1786
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Lepper, F. Ahrens, J. Weigl, F. Riedel (Hamburg, Kiel, Germany). Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment?. Eur Respir J 2006; 28: Suppl. 50, 1786

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010


Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012


A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 134s
Year: 2002

The role of the tracheal phonography in chronic obstructive lung disease and asthma diagnosis
Source: Annual Congress 2012 - Asthma management
Year: 2012

Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Source: Eur Respir J 2003; 21: 3S-9S
Year: 2003



A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients
Source: Eur Respir J 2007; 30: Suppl. 51, 177s
Year: 2007

Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005



The effect of statin therapy in patients with chronic obstructive airway disease
Source: International Congress 2015 – COPD: notable points
Year: 2015


The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2014; 44: 475-482
Year: 2014



Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008


The effect of inhaled corticosteroids on bronchoalveolar lavage interleukin-8 levels and cell percentage in stable chronic obstructive pulmonary disease patients
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001

Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003



Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002



Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012


Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006